Oppenheimer Asset Management Inc. Acquires 610 Shares of Intuitive Surgical, Inc. $ISRG

Oppenheimer Asset Management Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 53,308 shares of the medical equipment provider’s stock after acquiring an additional 610 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Intuitive Surgical were worth $28,968,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in ISRG. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the last quarter. Invesco Ltd. raised its stake in Intuitive Surgical by 1.7% in the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after purchasing an additional 71,794 shares in the last quarter. Northern Trust Corp raised its stake in Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after purchasing an additional 11,988 shares in the last quarter. Wellington Management Group LLP raised its stake in Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Nuveen LLC bought a new position in Intuitive Surgical in the first quarter valued at about $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the sale, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 40,724 shares of company stock valued at $19,500,332 in the last quarter. 0.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on ISRG. HSBC lifted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday. Rothschild & Co Redburn lifted their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday. Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday. Finally, Jefferies Financial Group upped their target price on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $602.32.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $546.51 on Friday. The stock has a market capitalization of $195.91 billion, a price-to-earnings ratio of 72.29, a PEG ratio of 5.45 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business’s fifty day moving average is $458.09 and its 200-day moving average is $497.29.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.84 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.